Cellular Signaling Lecture

G-proteins

GPCR acts as a GEF; activates alpha subuint of G-protein; alpha then dissociates from beta and gamma units to go activate targets.

Target: Enzyme

Signal amplification occurs w/ second messenger

2nd Messenger: Adenyly cyclase - cAMP

2nd Messenger: Phospholipase C- (PLC Beta),Diacylglycerol (DAG), IP3, Ca2+

Target: Ion channel

Effect: Change in PM permeability

cAMP targets protein kinase A (PKA), gated ion channels, and/or exchange protein activated by cAMP (EPAC)

Inactivation: Phosphodiesterase (PDE)

Phosphodiesterase inhibitors increase cAMP by preventing its degradation

Toxins alter cAMP signaling by modifying G(alpha)i

G(alpha) s stimulates cAMP; G(alpha)i inhibits cAMP

Cholera

Pertussis

Inactivates G(alpha)i. Prevents cAMP inhibition; increased cAMP.

Inhibits G(alpha)s; increases cAMP

Through PKA (serine/threonine kinase), CFTR increases Cl- transport and MLCK for smooth muscle relaxation.

A kinase anchoring proteins (AKAPs) are scaffolds, promoting specificity.

PKA can phosphorylate cAMP response element binding protein (CREB) to active CRE to activate transcription

CRE acts in long-term changes like learning and memory.

PLC beta activated by Gq protein. Activation of PLC B cleaves PIP2 to IP3 and DAG.

DAG serves as a receptor of sorts on protein kinase C on the PM.

IP3 binds to an ER receptor, releasing calcium

Protein: Calmodulin (CaM) will bind to released calcium and activate CaM kinase

Kinase activates myosin light chain kinase (MLCK) for contractions

This seems to do the inverse of cAMP activation of MLCK

Regulator of G-protein signaling (RGS) acts as GAPs.

Use of GAPs cause re-association of subunits that dissociated as a result of activation.

Enzyme Coupled Receptors

Serine/threonine kinase: TGF Beta receptor

These sort of receptors dimerize w/ activation and has enzymatic activity due to being coupled or intrinsically.

Regulates proliferation and ECM deposition

TGFB binds to its type 2 receptor. Results in recruitment and phosphorylation of type 1 heterodimer

Type 1 phosphorylates Smad2/3. Smad2/3 then dissociate and go bind to Smad4

Smad4 translocates to nucleus to regulate gene transcription.

Disease: Interstitial pulmonary fibrosis - TGF beta drives myofibroblast proliferation and collagen disposition

Receptor Tyrosine kinases (RTKs)

Activation results in dimerization

Promotes trans-autophosphorylation where each part of the receptor polypeptides phosphorylates the others

Proteins downstream w/ SH2 domain lik Grb2 binds to activated RTK.

Drug: Imatinib used to treat leukemia and some GI tumors.

Grb2 recruits Ras-GEF, activating Ras.

Ras activates and activates MEK. MEK activates MAPK (Erk)

Erk can phosphorylates protein in cytosol or go to the nucleus and alter gene expression via phosphorylation of gene regulatory proteins.

Tyrosine kinase-associated receptors: JAK or Janus kinases

RTK recruits STAT proteins via SH2 domain.

STAT phosphorylated by JAKs go to the nucleus to activate gene transcription.

Protein Kinase C is involved in inhibiting the insulin signaling that recruits Glut4 channels to the membrane for glucose intake.